The device that has been developed is a chip capable of monitoring tumor indicators in the bloodstream of people, this monitoring aims to detect the tumor early when cancer proteins are at low levels.
Current diagnostic methods detect the carcinogenic tumour when markers indicate a high protein concentration, i.e. in the stages following its formation.
The chip can analyze blood or urine and the low voltage application running the sample analysis. And it also contains several sensors that are distributed in the micro fluid network, allowing multiple analysis. So it allows you to develop a risk analysis on the type of cancer to be treated.
The most fascinating thing about the discovery is that we are able to detect extremely low concentrations of this protein within minutes, which makes this device a state-of-the-art tool, an ultra-sensitive and powerful instrument that will improve early detection and monitoring of cancer treatment," said the project leader, Romain Quidant, in an interview.
Editing and content:
